Chinese approval for Food Detective® test

RNS Number : 0156E
Omega Diagnostics Group PLC
03 November 2020
 

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Chinese approval for self-test use of Food Detective® test

 

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that the   National Medical Products Administration ("NMPA"), formerly the China Food and Drug Administration, has approved the Company's Food Detective® test for self-test use in China .  

 

Further to the announcement on 2 April 2020 confirming NMPA approval for laboratory use of the Food Detective® test in China, Omega's development team has continued to work in conjunction with its distribution partner to support their efforts to achieve NMPA approval to allow the test to be used in people's homes.

 

The Company will support its distribution partner to ensure that Food Detective® achieves commercial success in China as an approved home-use test.

 

Colin King, CEO of Omega commented: "I am delighted to receive self-test approval in China which was a key commercial objective for this year. This is another excellent reward for all the hard work put in by both our and our partner's teams in what has remained challenging times around the world."

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

Contacts: 

 

Omega Diagnostics Group PLC 

Tel: 01259 763 030

Bill Rhodes, Interim Non-Executive Chairman

Colin King, Chief Executive 

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director




finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash/Edward Whiley (Corporate Finance)


Alice Lane (ECM)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUUAKRROUARAA
UK 100